Specific Substances: Clorazepate
Nomination Date: 03/31/1986
Nominator: NIEHS, FDA
Rationale: Widespread use including use by pregnant women; development of data on structure-activity relationships with regard to carcinogenic potential; and lack of existing studies.
Agents and Status
The following information relates to the specific agent and may include history from earlier or later nominations for this same agent.
Agent Name: Clorazepate